Linzagolix

DRUG3 trials

Sponsors

ObsEva SA, Centro A.M.B.R.A. (Associazione Medici e Biologi per la Riproduzione Assistita)

Conditions

Healthy ParticipantsHepatic ImpairmentInfertility, FemaleOvulation InductionRenal Impairment

Phase 1

Safety and Pharmacokinetics of Linzagolix in Female Subjects With Normal and Impaired Renal Function

CompletedNCT03961932

ObsEva SAHealthy Participants, Renal Impairment

Start: 2019-05-15End: 2020-01-31Updated: 2020-03-05

Safety and Pharmacokinetics Study of Linzagolix in Female Subjects With Normal and Impaired Hepatic Function

CompletedNCT03962049

ObsEva SAHealthy Participants, Hepatic Impairment

Start: 2019-05-15End: 2019-11-01Updated: 2020-01-13

Unknown Phase

Oral GnRH Antagonist (Linzagolix) Versus Injectable GnRH Antagonist and Progestin-primed Ovarian Stimulation (PPOS) in Controlled Ovarian Stimulation for in Vitro Fertilization: a Prospective Comparative Observational Study

Not yet recruitingNCT07732348

Centro A.M.B.R.A. (Associazione Medici e Biologi per la Riproduzione Assistita)Infertility, Female, Ovulation Induction

Start: 2026-09-01End: 2026-12-01Target: 195Updated: 2026-08-03